Comparison of the CHADS2, CHA2DS2 -VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Thrombosis and Haemostasis

• Publication date

  2013-09-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH13-07-0552PMID 24048467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative assessment of the HAS-BLED score with other published bleeding risk scoring schemes, for intracranial haemorrhage risk in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study.

  2013cited by this paper
• Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

  2013cited by this paper
• The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation

  2012cited by this paper
• The ATRIA risk scheme to predict warfarin-associated hemorrhage not ready for clinical use.

  2012cited by this paper
• Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation

  2012cited by this paper
• Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.

  2012cited by this paper
• Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study

  2012cited by this paper
• Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

  2012influential reference
• Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.

  2012cited by this paper
• Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.

  2012cited by this paper
• Oral anticoagulation use by patients with atrial fibrillation in Germany

  2012cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Bleeding risk assessment and management in atrial fibrillation patients

  2011cited by this paper
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial

  2011cited by this paper
• Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

  2011cited by this paper
• Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

  2011cited by this paper
• The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage Not Ready for Clinical Use

  2011cited by this paper
• A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

  2010cited by this paper
• Statistical methods for assessment of added usefulness of new biomarkers

  2010cited by this paper
• Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.

  2008cited by this paper
• Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.

  2007cited by this paper
• Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

  2007cited by this paper
• Decision Curve Analysis: A Novel Method for Evaluating Prediction Models

  2006influential reference
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper

• Acute lower gastrointestinal bleeding.

  2024cites this paper
• Using machine learning to develop a clinical prediction model for SSRI-associated bleeding: a feasibility study

  2023cites this paper
• An analysis of antithrombotic therapy in elderly patients with atrial fibrillation undergoing percutaneous coronary interventions

  2023influential citation
• Outcomes associated with antithrombotic strategies in heart failure with reduced ejection fraction and sinus rhythm following acute ischemic stroke

  2022cites this paper
• Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.

  2022cites this paper
• Stroke in hemodialysis patients and its association with CHA2DS2-VASC and HAS-BLED scores: a retrospective study

  2022cites this paper
• Stroke risk scores for prediction of mortality and hemorrhages in atrial fibrillation patients

  2022cites this paper
• Highlights and comments on EHRA/HRS/APHRS/LAHRS expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome

  2021cites this paper
• Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? a nationwide cohort study.

  2021cites this paper
• Stroke Risk Scores as Predictors of Severe Outcomes in Atrial Fibrillation: A Comprehensive Review

  2021cites this paper
• Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation

  2021cites this paper
• Anticoagulant selection in relation to the SAMe-TT 2 R 2 score in patients with atrial fi brillation: The GLORIA-AF registry Hellenic Journal of Cardiology

  2021cites this paper
• Atrial Fibrillation and Stroke.

  2021cites this paper
• Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

  2021cites this paper
• Comorbidities Associated with Worse Outcomes Among Inpatients Admitted for Acute Gastrointestinal Bleeding

  2021cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• Anticoagulant Selection in Relation to SAMe-TT2R2 Score in Patients with Atrial Fibrillation: The GLORIA-AF Registry.

  2020cites this paper
• Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice

  2020cites this paper
• Circulation: Cardiovascular Interventions

  2020cites this paper
• Treatment of the Dental Patient with Bleeding Dyscrasias: Etiologies and Management Options for Surgical Success in Practice.

  2020cites this paper
• Atrial Fibrillation in Heart Failure: Focus on Antithrombotic Management.

  2020cites this paper
• The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications

  2020cites this paper
• Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation

  2020cites this paper
• Quality indicators for the care and outcomes of adults with atrial fibrillation.

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

  2020cites this paper
• Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy

  2020cites this paper
• European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population

  2020cites this paper
• Combination of Oral Anticoagulants and Single Antiplatelets versus Triple Therapy in Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome: Stroke Prevention among Asians

  2020cites this paper
• Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: A real‐world study in Chinese patients

  2019cites this paper
• Prognostic value of von Willebrand factor for patients with atrial fibrillation: a meta-analysis of prospective cohort studies

  2019cites this paper
• Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy: an Austrian interdisciplinary consensus statement

  2019cites this paper
• Cerebrovascular accidents in Ebstein's anomaly.

  2019cites this paper
• Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation

  2018cites this paper
• Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation

  2018cites this paper
• Anticoagulation Resumption After Intracerebral Hemorrhage

  2018cites this paper
• Major hemorrhages in patients treated with oral anticoagulants: choice of management in the emergency room.

  2018cites this paper
• Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation.

  2018cites this paper
• Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

  2018cites this paper
• Stroke Prevention in Patients With Atrial Fibrillation: A Systematic Review Update

  2018influential citation
• OP-EUPA180177 1..27

  2018cites this paper
• 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European

  2018cites this paper
• [Anticoagulant therapy in atrial fibrillation with acute coronary syndrome in real clinical practice according to the total register of acute coronary syndrome in the Krasnodar Territory].

  2018cites this paper
• Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation

  2017cites this paper
• Direct oral anticoagulant reversal: how, when and issues faced

  2017cites this paper
• Secondary Versus Primary Stroke Prevention in Atrial Fibrillation: Insights From the Darlington Atrial Fibrillation Registry

  2017cites this paper
• Stroke Prevention in Atrial Fibrillation

  2017cites this paper
• Management von schwerwiegenden intrazerebralen Blutungen unter Antikoagulation

  2017cites this paper
• Validación de la escala de riesgo hemorrágico HAS-BLED en una población hospitalaria de nuestro medio

  2017influential citation
• The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.

  2017cites this paper
• Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors∗

  2017cites this paper
• Acute Management of Anticoagulation-Associated Intracerebral Hemorrhage

  2017cites this paper
• Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing

  2017cites this paper
• Timing of Carotid Revascularization Procedures After Ischemic Stroke

  2017cites this paper
• Performance of bleeding risk scores in dialysis patients.

  2017cites this paper
• Comparison of the CHA2DS2-VASc, CHADS2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.

  2017cites this paper
• Resumption of Anticoagulation After Intracranial Hemorrhage

  2017cites this paper
• University of Birmingham Secondary versus primary stroke prevention in atrial fibrillation

  2017cites this paper
• Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation

  2017cites this paper
• Optimal antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: A systemic review and meta-analysis

  2017influential citation
• Guideline‐Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community‐Based Darlington Atrial Fibrillation Registry

  2017cites this paper
• Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.

  2016cites this paper
• Emerging Tools for Stroke Prevention in Atrial Fibrillation

  2016influential citation
• Difficult situations in anticoagulation after stroke: between Scylla and Charybdis.

  2016cites this paper
• Choosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to Know.

  2016cites this paper
• Determinants of effective, safe and convenient vitamin K antagonist use

  2016cites this paper
• Administration of Coagulation-Altering Therapy in the Patient Presenting for Oral Health and Maxillofacial Surgery.

  2016cites this paper
• International Validity of the HOSPITAL Score to Predict 30-Day Potentially Avoidable Hospital Readmissions.

  2016cites this paper
• Assessment and comparison of CHADS2, CHA2DS2-VASc, and HAS-BLED scores in patients with atrial fibrillation in Saudi Arabia

  2016cites this paper
• Drug-drug interactions of non-vitamin K oral anticoagulants

  2016cites this paper
• Validation Of The HAS-BLED Tool In Atrial Fibrillation Patients Receiving Rivaroxaban.

  2016cites this paper
• Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores

  2016cites this paper
• Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy.

  2016cites this paper
• Stroke prevention in atrial fibrillation: a systematic review.

  2015cites this paper
• Stroke prevention in atrial fibrillation: changing concepts.

  2015cites this paper
• Editors’ Choice papers in Thrombosis and Haemostasis

  2015cites this paper
• OPINION Difficult situations in anticoagulation after stroke: between Scylla and Charybdis

  2015cites this paper
• Safety and outcome of coronary interventions with special reference to anticoagulation and stent type

  2015cites this paper
• Editors' Choice papers in Thrombosis and Haemostasis.

  2015cites this paper
• C URRENT OPINION Difficult situations in anticoagulation after stroke: between Scylla and Charybdis

  2015cites this paper
• Risk of Bleeding and Stroke with Oral Anticoagulation and Antiplatelet Therapy in Patients with Atrial Fibrillation in Taiwan: A Nationwide Cohort Study

  2015cites this paper
• European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care

  2015cites this paper
• Old And New Oral Anticoagulants In Management Of Atrial Fibrillation: A Double-Edged Sword For Women.

  2015cites this paper
• The changing characteristics of atrial fibrillation patients treated with warfarin

  2015cites this paper
• Assessing Bleeding Risk With the HAS‐BLED Score: Balancing Simplicity, Practicality, and Predictive Value in Bleeding‐Risk Assessment

  2015cites this paper
• Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications.

  2015cites this paper
• The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis

  2015cites this paper
• A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC

  2015cites this paper
• Stroke prevention in atrial fibrillation: An Asian perspective

  2014cites this paper
• Atrial fibrillation and stroke prevention: brief observations on the last decade

  2014cites this paper
• In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS2 and CHA2DS2-VASc

  2014cites this paper
• A Case Of Difficult Epicardial Access For Ablation Of Ventricular Tachcyardia.

  2014cites this paper
• Management of Atrial Fibrillation in Patients With Kidney Disease.

  2014cites this paper
• The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.

  2014influential citation
• Assess bleeding risk with HAS-BLED and assess stroke risk with CHA2DS2-VASc in patients with atrial fibrillation

  2014cites this paper
• Erratum to “Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants”

  2014cites this paper
• Managing anticoagulant therapies using innovative thrombin generation assays

  2014cites this paper
• Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients

  2014cites this paper
• Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.

  2014cites this paper
• Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?

  2014cites this paper
• Specific risk scores for specific purposes: use CHA2DS2-VASc for assessing stroke risk, and use HAS-BLED for assessing bleeding risk in atrial fibrillation.

  2014cites this paper